Richard Bethell, DPhil (he/him/his)

Chief Scientific Officer
Sulis Therapeutics
Copenhagen N, Hovedstaden, Denmark

Disclosure information not submitted.

Presentation(s):

• SP2H selectively depletes Stimulator of Interferon Genes (STING), reducing inflammation and improving survival in Trex1-/- mice

  Thursday, April 16, 2026
  8:15 AM - 8:30 AM US ET